Banca Mediolanum (BMED) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
8 Nov, 2025Executive summary
Net income for the first nine months of 2025 rose 8% year-over-year to €726 million, driven by strong commission and fee growth, robust net inflows, and effective execution across business lines.
Assets under management and administration reached €150.4 billion, up 8.6% from December 2024, with the customer base surpassing 2 million.
Managed asset inflows surged 21% YoY, supporting recurring fees and customer retention, while total net inflows grew 14% to €8.16 billion.
The Spanish business expanded in line with plans, with managed assets up 15–26% YoY and net income down 28% YoY due to investments and margin pressure.
The group distributed an interim dividend of €0.60 per share, with a total payout of approximately €443.5 million.
Financial highlights
Net commission income increased 11% YoY to €968.6 million, with management and investment management fees up 10% YoY to €1.24 billion.
Net interest income declined 5% YoY to €581.7 million, but is expected to narrow the gap versus last year and align with full-year guidance.
Operating margin grew 5% to €891.4 million; contribution margin up 5% to €1.56 billion.
Cost/income ratio improved to 37.2%, trending below 40% for year-end.
Total net inflows grew 14% to €8.16 billion, with managed asset inflows up 21% YoY to €6.58 billion.
Outlook and guidance
Managed asset net inflows guidance for 2025 is €8–8.5 billion, with similar strength expected in 2026 under normal market conditions.
Net interest income is projected to decline ~1% in 2025 but increase in 2026, potentially by double digits, assuming current yield curves.
Cost-to-income ratio expected below 40% and cost of risk around 20bps.
Dividend per share to increase, with the 2025 interim dividend at €0.60, including a €0.20 one-off from the Mediobanca stake sale.
Guidance assumes stable market conditions for 2026.
Latest events from Banca Mediolanum
- Record net income, strong asset growth, and a 25% higher dividend highlight a standout year.BMED
Q4 20253 Feb 2026 - Net income up 24% to EUR 449.9M, assets under administration EUR 129.5B, CET1 at 23.7%.BMED
Q2 20242 Feb 2026 - Net income up 18% to €674.3M, with record assets and higher interim dividend.BMED
Q3 202415 Jan 2026 - Record net income of €1.12B, €10.44B inflows, and 42% higher dividend proposed.BMED
Q4 20248 Jan 2026 - Net income up 10% YoY, record inflows, and strong capital ratios support 2025 outlook.BMED
Q1 20258 Jan 2026 - Net income up 6% to €477.3M, with record assets, strong inflows, and robust capital ratios.BMED
Q2 20251 Nov 2025